High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.
J Exp Clin Cancer Res. 2021 Oct 30;40(1):343. doi: 10.1186/s13046-021-02134-y.
J Exp Clin Cancer Res. 2021.
PMID: 34717701
Free PMC article.
Review.